| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/12/2002 | US6346613 An antisense oligonucleotide that hybridizes with a occludin mrna and disrupts tight junctions, to increase cell layer permeability to solutes and drugs |
| 02/12/2002 | US6346611 High affinity TGfβ nucleic acid ligands and inhibitors |
| 02/12/2002 | US6346548 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 02/12/2002 | US6346511 Pharmaceutical composition comprising cyclosporin |
| 02/12/2002 | US6346279 Antiseptics with phosphorous acid, anionic surfactants of alkylbenzenesulfonic acids and alkali or ammonium salts |
| 02/12/2002 | US6346275 Drugs for immunology residues of corallinaceae, seaweed derivatives |
| 02/12/2002 | US6346274 Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof |
| 02/12/2002 | US6346273 Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles |
| 02/12/2002 | US6346272 Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
| 02/12/2002 | US6346271 Treatment of skin disorders using polymer sodium hyaluronate dermatitis. |
| 02/12/2002 | US6346268 Tablet for drug release |
| 02/12/2002 | US6346263 Particles and matrices of graft polymers |
| 02/12/2002 | US6346254 Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives |
| 02/12/2002 | US6346248 Methods of treating autoimmune diseases with a CD86-specific immunotoxin |
| 02/12/2002 | US6346242 Compounds and compositions for delivering active agents |
| 02/12/2002 | US6346239 Use in cosmetics of a reverse latex of nitrogenous salts of polyacrylate, novel latices, process for their preparation and cosmetic compositions incorporating them |
| 02/12/2002 | US6346231 Flavored gelatin capsule and method of manufacture |
| 02/12/2002 | CA2303685C Fluorocarbon aerosol medicaments |
| 02/12/2002 | CA2207218C Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure |
| 02/12/2002 | CA2169087C Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same |
| 02/12/2002 | CA2131547C Composition for oral preparations |
| 02/12/2002 | CA2125500C Composition of antineoplastic agents incorporated in micelles |
| 02/12/2002 | CA2079780C Methods and formulations for stabilizing fibroblast growth factor |
| 02/12/2002 | CA2041378C Granulated preparations and method of producing the same |
| 02/12/2002 | CA2037569C Controlled release formulation |
| 02/07/2002 | WO2002010431A2 Functional biopolymer modification reagents and uses thereof |
| 02/07/2002 | WO2002010361A1 α-ISOMALTOSYLGLUCOSACCHARIDE SYNTHASE, PROCESS FOR PRODUCING THE SAME AND USE THEREOF |
| 02/07/2002 | WO2002010201A2 Peptide-mediated delivery of molecules into cells |
| 02/07/2002 | WO2002010193A1 Lipid-peptide conjugates for treatment of cancer |
| 02/07/2002 | WO2002009814A2 New use of lipase inhibitors |
| 02/07/2002 | WO2002009792A1 Bioabsorbable composites of derivatized hyaluronic acid |
| 02/07/2002 | WO2002009787A1 Microparticulate biomaterial composition for medical use |
| 02/07/2002 | WO2002009769A2 Therapeutic azo-compounds for drug delivery |
| 02/07/2002 | WO2002009768A2 Therapeutic polyesters and polyamides |
| 02/07/2002 | WO2002009767A2 Therapeutic polyanhydride compounds for drug delivery |
| 02/07/2002 | WO2002009766A1 Highly reactive branched polymer and proteins or peptides conjugated with the polymer |
| 02/07/2002 | WO2002009764A1 Combination compositions |
| 02/07/2002 | WO2002009763A2 Transdermal drug delivery system |
| 02/07/2002 | WO2002009729A2 Treatment of hyperproliferative skin disorders and diseases |
| 02/07/2002 | WO2002009724A1 Pharmaceutical compositions containing tobramycin and xanthan gum |
| 02/07/2002 | WO2002009716A2 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer |
| 02/07/2002 | WO2002009710A2 Paroxetine tablets and capsules |
| 02/07/2002 | WO2002009707A1 Fentanyl composition for nasal administration |
| 02/07/2002 | WO2002009704A2 Pharmaceutical composition for transdermal delivery of befloxatone |
| 02/07/2002 | WO2002009702A2 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
| 02/07/2002 | WO2002009690A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 02/07/2002 | WO2002009679A2 Use of 13-cis retinoic acid for the treatment of emphysema |
| 02/07/2002 | WO2002009678A2 Charged phospholipid compositions and methods for their use |
| 02/07/2002 | WO2002009675A1 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release |
| 02/07/2002 | WO2002009673A1 Granules based on starch and lactose |
| 02/07/2002 | WO2002009671A2 Microemulsion and micelle systems for solubilizing drugs |
| 02/07/2002 | WO2002009670A1 Liquid or semi-solid pharmaceutical excipient and pharmaceutical composition comprising the same |
| 02/07/2002 | WO2002009667A2 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/07/2002 | WO2002009649A2 Cell internalized peptide-drug conjugates |
| 02/07/2002 | WO2002009637A2 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |
| 02/07/2002 | WO2002009631A1 Vaginal delivery of bisphosphonates |
| 02/07/2002 | WO2001074395A3 Amiodarone-containing parenteral solution |
| 02/07/2002 | WO2001072339A3 Method of treatment of conditions involving obstruction of blood flow |
| 02/07/2002 | WO2001070271A3 Acid-stable base compositions for preparing surfactant free topical compositions |
| 02/07/2002 | WO2001068060A3 Stabilised oversaturated transdermal therapeutical matrix systems |
| 02/07/2002 | WO2001060417A3 Radioactive therapeutic liposomes |
| 02/07/2002 | WO2001058470A3 Methods for enhancing the bioavailability of a drug |
| 02/07/2002 | WO2001050866A3 Method and device for sanitation using bacteriophages |
| 02/07/2002 | WO2001049260A3 Y-ifn liquid-droplet aerosol and method |
| 02/07/2002 | WO2001044307A3 Degradable poly(vinyl alcohol) hydrogels |
| 02/07/2002 | WO2001040240A3 Mono- and disaccharide derivatives |
| 02/07/2002 | WO2001037803A3 Responsive polymeric hollow particles |
| 02/07/2002 | WO2001034206A3 Nucleic acid-containing complex |
| 02/07/2002 | WO2001029233A3 Chimeric immunogenic compositions and nucleic acids encoding them |
| 02/07/2002 | WO2000072883A9 Pharmaceutical transdermal compositions |
| 02/07/2002 | US20020016625 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 02/07/2002 | US20020016452 Soaking wood pulp in sodium hydroxide to produce alkali cellulose which is reacted with propylene oxide, the product is dissolved in water, precipitated, neutralized with acetic acid, washed, dried and grinded; pharmaceutical excipients |
| 02/07/2002 | US20020016373 Adding to the fluoroether compound selected from evoflurane, enflurane, isoflurane, methoxyflurane and desflurane an effective stabilizing amount of a lewis acid inhibitor to prevent the degradation of fluoroether |
| 02/07/2002 | US20020016369 Administration to a patient suffering from psoriasis or psoriatic arthritis an effective amount of Nimesulide or its salt or a complex with cyclodextrin |
| 02/07/2002 | US20020016320 Inhibiting beta-secretase enzyme activity and A beta peptide production. |
| 02/07/2002 | US20020016304 Carrier for stabilizing nucleic acid |
| 02/07/2002 | US20020016295 Keratinocyte growth factor-2 formulations |
| 02/07/2002 | US20020016292 Pharmaceutical compositions containing cyclosporins |
| 02/07/2002 | US20020016290 At least 50 weight percent of the cyclosporin present in the dispersion is of particles less than about 1 mu m, said cyclosporin being amorphous. |
| 02/07/2002 | US20020016288 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 02/07/2002 | US20020016285 Antitumor and/or antileukemic effects |
| 02/07/2002 | US20020016270 Solution for contact lenses |
| 02/07/2002 | US20020015984 Methods for ansamitocin production |
| 02/07/2002 | US20020015757 Xanthan gum broth |
| 02/07/2002 | US20020015737 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 02/07/2002 | US20020015735 Oral administering |
| 02/07/2002 | US20020015734 Mixture of protein and heat sensitive polymer |
| 02/07/2002 | US20020015733 Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| 02/07/2002 | US20020015732 Formulation of a 5 alpha reductase inhibitor for oral administrtion, and a preparation process and use thereof |
| 02/07/2002 | US20020015731 Hydrogel-Driven Drug Dosage Form |
| 02/07/2002 | US20020015730 Pharmaceutical formulations and method for making |
| 02/07/2002 | US20020015729 Colonic delivery of weak acid drugs |
| 02/07/2002 | US20020015728 Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 02/07/2002 | US20020015721 Dispersion containing nonionic surfactants |
| 02/07/2002 | US20020015720 Polymer blends as biodegradable matrices for preparing biocomposites |
| 02/07/2002 | US20020015715 Inducing interferon and tumor necrosis factor locally in the skin or mucous memebranes by applying 4-amino-2-ethoxymethyl-alpha,alpha-di methyl-1H-imidazo(4,5-c)quinoline-1-ethanol, silica sol, triacetin and propylene glycol |
| 02/07/2002 | US20020015713 An amine containing compound such as the antidepressant dioxepin or the muscle relaxant guaifenesin and carriers |
| 02/07/2002 | US20020015712 Temperature controlled solute delivery system |
| 02/07/2002 | US20020015705 Three-step pretargeting methods and compounds |
| 02/07/2002 | US20020015687 Method for the anhydrous loading of nicotine onto ion exchange resins |